Aptose Biosciences (APTO)

Aptose Biosciences (APTO) Financial Statements


Aptose Biosciences Financial Overview

Aptose Biosciences's market cap is currently ―. The company's EPS TTM is $-0.453; its P/E ratio is -1.42; Aptose Biosciences is scheduled to report earnings on May 9, 2023, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -10.03M$ -10.67M$ -11.50M$ -24.35M$ -11.36M
EBITDA$ -9.88M$ -10.53M$ -11.35M$ -24.18M$ -11.20M
Net Income Common Stockholders$ -9.78M$ -10.56M$ -11.48M$ -24.32M$ -11.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 55.39M$ 62.41M$ 69.51M$ 79.13M$ 95.10M
Total Assets$ 57.05M$ 64.81M$ 72.60M$ 82.53M$ 97.20M
Total Debt$ 271.00K$ 401.00K$ 529.00K$ 574.00K$ 700.00K
Net Debt$ -55.12M$ -62.01M$ -68.98M$ -78.55M$ -94.40M
Total Liabilities$ 10.23M$ 9.31M$ 7.32M$ 8.29M$ 8.52M
Stockholders Equity$ 46.81M$ 55.49M$ 65.28M$ 74.24M$ 88.68M
Cash Flow-
Free Cash Flow$ -6.98M$ -7.07M$ -9.64M$ -16.06M$ -8.24M
Operating Cash Flow$ -6.98M$ -7.05M$ -9.64M$ -16.04M$ -8.06M
Investing Cash Flow$ -5.08M$ 10.07M$ 7.50M$ -20.01M$ -185.00K
Financing Cash Flow$ 21.00K$ 29.00K$ 15.00K$ 66.00K$ 0.00
Currency in USD

Aptose Biosciences Earnings and Revenue History

Aptose Biosciences Debt to Assets

Aptose Biosciences Cash Flow

Aptose Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis